The study found that Doxapram could block the upregulation of atrial TASK-1 current and associated shortening of the action potential duration (APD), successfully inducing acute cardioversion in paroxysmal AF and rhythm control in persistent AF. The gene discussed is KCNK3; the disease is Paroxysmal atrial fibrillation.